The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells (Q39472127)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 September 2011

Language	Label	Description	Also known as
English	The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells	scientific article published on 19 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mario Durán-Prado

object named as

M Durán-Prado

1

0 references

Gema Moreno-Bueno

object named as

G Moreno-Bueno

8

0 references

author name string

M D Gahete

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

M Hergueta-Redondo

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

A J Martínez-Fuentes

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

J Córdoba-Chacón

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

J Palacios

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

F Gracia-Navarro

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

M M Malagón

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

R M Luque

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

J P Castaño

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

19 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2049-2061

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Pituitary somatostatin receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Somatostatin Inhibits Akt Phosphorylation and Cell Cycle Entry, But Not p42/p44 Mitogen-Activated Protein (MAP) Kinase Activation in Normal and Tumoral Pancreatic Acinar Cells1

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Sphingosine-1-phosphate signaling regulates lamellipodia localization of cortactin complexes in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Roles of AKT signal in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Somatostatin receptors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Effect of WAVE2 phosphorylation on activation of the Arp2/3 complex.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Anti-migratory and anti-invasive effect of somatostatin in human neuroblastoma cells: involvement of Rac and MAP kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

The role of mitogen-activated protein (MAP) kinase in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Increased phosphorylation of Akt in triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Somatostatin-receptor scintigraphy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Tumor cells caught in the act of invading: their strategy for enhanced cell motility.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Biology of somatostatin in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Phosphorylation and regulation of Raf by Akt (protein kinase B)

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.389

31 March 2020

Identifiers

10.1038/ONC.2011.389

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39472127&oldid=2202910706"